GlassScriptPhysician profile
Roxana L Vega
NPI 1124274204
$2,816.01
in general payments reported to CMS, 2019-2025
22 companies · $1,120 in 2025
The $1,120 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.28 · 2022: $246 · 2023: $512 · 2024: $912 · 2025: $1,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,511 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,511.42 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $379.05 | 2022-2023 | Gallant, Merlin@Home |
| Merck Sharp & Dohme LLC | $375.76 | 2023-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $321.01 | 2023-2025 | |
| Amgen INC. | $218.08 | 2022-2025 | Repatha, Repatha |
| Novo Nordisk INC | $196.08 | 2023-2025 | Wegovy, Ozempic |
| Cvrx, INC. | $179.88 | 2025 | Barostim Neo System |
| Recor Medical INC | $172.67 | 2025 | Paradise Ultrasound Renal Denervation System |
| Medicomp INC | $167.31 | 2024-2025 | Telepatch Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $140.36 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $132.48 | 2022-2024 | Lokelma |
| Lexicon Pharmaceuticals, INC. | $122.99 | 2024 | Inpefa |
| Bridgebio Pharma, INC. | $103.53 | 2025 | Attruby |
| Impulse Dynamics (USA) INC. | $49.07 | 2024 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $42.84 | 2025 | |
| Glaxosmithkline, LLC. | $41.73 | 2025 | Shingrix, Arexvy |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $40.81 | 2023 | Ffrct |
| Pfizer INC. | $29.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $27.02 | 2022 | |
| Boston Scientific Corporation | $26.60 | 2023 | |
| Kestra Medical Technology Services, INC. | $21.63 | 2025 | Assure Wcd |
| Amarin Pharma, INC. | $14.35 | 2021 | |
| G Medical Diagnostic Services, INC. | $13.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roxana Vega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.